Current Contracts
Program Solicitation PHS 2022-1
View Solicitation
Receipt Date: October 28, 2021, 5 p.m. Eastern Daylight Time
Q&A Amendment 1 issued on September 23, 2021
Applicants must use the Contract Proposal Submission (eCPS) website to submit their proposal. No other method of proposal submission is permitted. Instructions for electronic submission are provided in the solicitation. Actual contract topic numbers will be available in the solicitation.
The PHS 2022-1 Solicitaton includes following 16 contract topics released by the National Cancer Institute:
|
TOPIC NUMBER |
TOPIC TITLE |
|
NIH/NCI 430 |
|
|
NIH/NCI 431 |
|
|
NIH/NCI 432 |
|
|
NIH/NCI 433 |
Developing Unbiased Medical Technologies to Reduce Disparities in Cancer Outcomes |
|
NIH/NCI 434 |
Ultra-fast Dose Rate (FLASH) Radiation Detectors and Safety Systems |
|
NIH/NCI 435 |
Devices to Treat Secondary Lymphedema Following Cancer Treatment |
|
NIH/NCI 436 |
|
|
NIH/NCI 437 |
3D Spatial Omics for Molecular and Cellular Tumor Atlas Construction |
|
NIH/NCI 438 |
Understanding Cancer Tumor Genomic Results: Technology Applications for Community Providers |
|
NIH/NCI 439 |
Advanced Sample Processing Platforms for Downstream Single-cell Multi-omic Analysis |
|
NIH/NCI 440 |
Cancer Prevention and Diagnosis Technologies for Low-resource Settings |
|
NIH/NCI 441 |
|
|
NIH/NCI 442 |
Quantitative Biomarkers as Medical Device Development Tools for Cancer |
|
NIH/NCI 443 |
|
|
NIH/NCI 444 |
Evaluation Datasets as Medical Device Development Tools for Testing Cancer Technologies |
|
NIH/NCI 445 |
Advanced Manufacturing to Speed Availability of Emerging Autologous Cell-based Therapies |
For contract inquiries, contact:
Cherie Wells
Contracts Analyst
Office of Acquisitions
E-mail: ncioasbir@mail.nih.gov
CLICK HERE to view past contract topics.